Results of the randomized phase IIB ARCTIC trial of low dose Rituximab in previously untreated CLL

Howard, DR orcid.org/0000-0003-3333-9783, Munir, T, McParland, L et al. (12 more authors) (2017) Results of the randomized phase IIB ARCTIC trial of low dose Rituximab in previously untreated CLL. Leukemia, 31. pp. 2416-2425. ISSN 0887-6924

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 Macmillan Publishers Limited. All rights reserved. This is an author produced version of a paper published in Leukemia. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Accepted: 8 March 2017
  • Published (online): 24 March 2017
  • Published: 2 May 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Haematology (Leeds)
Funding Information:
FunderGrant number
NHS HTA07/01/1938
Depositing User: Symplectic Publications
Date Deposited: 26 Apr 2017 11:18
Last Modified: 05 Jan 2018 15:47
Status: Published
Publisher: Nature Publishing Group
Identification Number: https://doi.org/10.1038/leu.2017.96

Share / Export

Statistics